DD201754A5 - Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung - Google Patents
Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung Download PDFInfo
- Publication number
- DD201754A5 DD201754A5 DD81233513A DD23351381A DD201754A5 DD 201754 A5 DD201754 A5 DD 201754A5 DD 81233513 A DD81233513 A DD 81233513A DD 23351381 A DD23351381 A DD 23351381A DD 201754 A5 DD201754 A5 DD 201754A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- protein
- treatment agent
- wound
- methacrylic acid
- gel
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 26
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims description 10
- 206010052428 Wound Diseases 0.000 claims abstract description 44
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 44
- 150000004676 glycans Chemical class 0.000 claims abstract description 16
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 16
- 239000005017 polysaccharide Substances 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 13
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920001184 polypeptide Polymers 0.000 claims abstract description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 11
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 8
- 229920000642 polymer Polymers 0.000 claims abstract description 5
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 3
- 239000007864 aqueous solution Substances 0.000 claims abstract 2
- 239000003505 polymerization initiator Substances 0.000 claims abstract 2
- 239000000499 gel Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 230000008961 swelling Effects 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 229920000936 Agarose Polymers 0.000 claims description 4
- 229920000620 organic polymer Polymers 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803036033 DE3036033A1 (de) | 1980-09-24 | 1980-09-24 | Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD201754A5 true DD201754A5 (de) | 1983-08-10 |
Family
ID=6112757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD81233513A DD201754A5 (de) | 1980-09-24 | 1981-09-23 | Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4554156A (cs) |
| EP (1) | EP0048323B1 (cs) |
| JP (1) | JPS5782313A (cs) |
| AR (1) | AR227931A1 (cs) |
| AT (1) | ATE12894T1 (cs) |
| AU (1) | AU527435B2 (cs) |
| CA (1) | CA1171787A (cs) |
| CS (1) | CS236470B2 (cs) |
| DD (1) | DD201754A5 (cs) |
| DE (2) | DE3036033A1 (cs) |
| DK (1) | DK154805C (cs) |
| ES (1) | ES8301640A1 (cs) |
| FI (1) | FI72654C (cs) |
| HU (1) | HU186784B (cs) |
| NO (1) | NO153035C (cs) |
| PL (1) | PL233144A1 (cs) |
| ZA (1) | ZA816594B (cs) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE82511T1 (de) * | 1982-04-22 | 1992-12-15 | Squibb & Sons Inc | Granulate zur verwendung bei der behandlung von wunden. |
| US4652443A (en) * | 1983-06-07 | 1987-03-24 | Japan Atomic Energy Research Institute | Slow-release composite and process for producing the same |
| GB2148901A (en) * | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
| EP0172191B1 (en) * | 1984-02-03 | 1989-12-27 | Scott Paper Company | Modified cellulose fibres |
| SE460017B (sv) * | 1984-03-14 | 1989-09-04 | Landstingens Inkopscentral | Bakterieadsorberande komposition i vattenoloeslig form |
| GB8422950D0 (en) * | 1984-09-11 | 1984-10-17 | Warne K J | Hydrogel |
| US5022413A (en) * | 1988-04-21 | 1991-06-11 | Spina Jr Joseph | Intralenticular cataract surgical procedure |
| US5438076A (en) * | 1988-05-03 | 1995-08-01 | Perio Products, Ltd. | Liquid polymer composition, and method of use |
| US5160737A (en) * | 1988-05-03 | 1992-11-03 | Perio Products Ltd. | Liquid polymer composition, and method of use |
| DE3903672C1 (cs) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
| US5035890A (en) * | 1989-04-10 | 1991-07-30 | Dow Corning Corporation | Emulsifier-free hand and body lotion |
| US7871637B2 (en) | 1996-08-27 | 2011-01-18 | Baxter International Inc. | Dry hemostatic compositions and methods for their preparation |
| US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US6063061A (en) * | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
| US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
| US7435425B2 (en) * | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
| AU2002361902A1 (en) * | 2001-12-31 | 2003-07-24 | Ares Medical, Inc. | Hemostatic compositions and methods for controlling bleeding |
| GB2384187A (en) * | 2002-01-22 | 2003-07-23 | Johnson & Johnson Medical Ltd | Particulate wound dressing |
| US8323693B2 (en) | 2002-03-14 | 2012-12-04 | Medrx Co., Ltd. | External preparation for wounds |
| US8834864B2 (en) | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
| US7927626B2 (en) * | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| US8252339B2 (en) * | 2006-04-11 | 2012-08-28 | Massachusetts Institute Of Technology | Medical treatment applications of swellable and deformable microspheres |
| AU2007267338B2 (en) | 2006-05-31 | 2013-04-04 | Baxter Healthcare S.A. | Method for directed cell in-growth and controlled tissue regeneration in spinal surgery |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
| US8114159B2 (en) * | 2006-11-20 | 2012-02-14 | Depuy Spine, Inc. | Anterior spinal vessel protector |
| TWI461227B (zh) | 2007-10-30 | 2014-11-21 | Baxter Int | 再生生物功能性膠原生物基質用來治療內臟或體壁缺陷的用途 |
| US20100311026A1 (en) | 2009-06-03 | 2010-12-09 | Tomes Jennifer E | Catheter Tray, Packaging System, and Associated Methods |
| US8678190B2 (en) | 2009-06-30 | 2014-03-25 | Medline Industries, Inc. | Catheter tray, packaging system, instruction insert, and associated methods |
| US8448786B2 (en) * | 2009-06-30 | 2013-05-28 | Medline Industries, Inc. | Catheter tray, packaging system, instruction insert, and associated methods |
| US8631935B2 (en) | 2009-06-03 | 2014-01-21 | Medline Industries, Inc. | Catheter tray, packaging system, and associated methods |
| CA2716872C (en) | 2008-02-29 | 2015-02-10 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
| US9162006B2 (en) | 2009-06-16 | 2015-10-20 | Baxter International Inc. | Hemostatic sponge |
| KR101811070B1 (ko) | 2009-12-16 | 2017-12-20 | 백스터 인터내셔널 인코포레이티드 | 지혈 스폰지 |
| SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
| JP6289096B2 (ja) | 2010-06-01 | 2018-03-07 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 乾燥した安定な止血組成物を作製するためのプロセス |
| US9084728B2 (en) | 2010-06-01 | 2015-07-21 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
| CN103037845B (zh) | 2010-06-01 | 2015-11-25 | 巴克斯特国际公司 | 用于制备干燥、稳定的止血组合物的方法 |
| MX346958B (es) | 2011-10-11 | 2017-04-06 | Baxter Int | Composición hemostatica. |
| CN103957949B (zh) | 2011-10-11 | 2017-07-18 | 巴克斯特国际公司 | 止血组合物 |
| EP2771027B1 (en) | 2011-10-27 | 2015-08-19 | Baxter International Inc | Hemostatic compositions |
| IN2014DN08122A (cs) | 2012-03-06 | 2015-05-01 | Ferrosan Medical Devices As | |
| CN104349797B (zh) | 2012-06-12 | 2017-10-27 | 弗罗桑医疗设备公司 | 干止血组合物 |
| CN105358071B (zh) | 2013-06-21 | 2018-07-31 | 弗罗桑医疗设备公司 | 真空膨胀的干组合物和用于保留该干组合物的注射器 |
| AU2014361291B2 (en) | 2013-12-11 | 2017-11-30 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
| JP6726852B2 (ja) | 2014-10-13 | 2020-07-22 | フェッローサン メディカル ディバイス エー／エス | 止血および創傷治癒に使用するための乾燥組成物 |
| RU2705905C2 (ru) | 2014-12-24 | 2019-11-12 | Ферросан Медикал Дивайсиз А/С | Шприц для удерживания и смешивания первого и второго веществ |
| CA2986981A1 (en) | 2015-07-03 | 2017-01-12 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| ES2968412T3 (es) | 2018-05-09 | 2024-05-09 | Ferrosan Medical Devices As | Método para preparar una composición hemostática |
| CN114306242B (zh) * | 2021-12-29 | 2023-04-25 | 广州佰斯伦医疗器械有限公司 | 含生长因子纳米凝胶的脂质体微粒及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3618213A (en) * | 1970-04-27 | 1971-11-09 | Nat Patent Dev Corp | Denture liners |
| SE452109B (sv) * | 1973-01-29 | 1987-11-16 | Pharmacia Ab | Rengoringsmedel for vetskande utvertes sarytor |
| US3963685A (en) * | 1974-05-13 | 1976-06-15 | Abrahams Robert A | Alcohol soluble hydrophilic polymer via aqueous polymerization |
| US4090013A (en) * | 1975-03-07 | 1978-05-16 | National Starch And Chemical Corp. | Absorbent composition of matter |
| DE2725261C2 (de) * | 1977-06-03 | 1986-10-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung |
-
1980
- 1980-09-24 DE DE19803036033 patent/DE3036033A1/de not_active Withdrawn
-
1981
- 1981-07-21 EP EP81105755A patent/EP0048323B1/de not_active Expired
- 1981-07-21 DE DE8181105755T patent/DE3170119D1/de not_active Expired
- 1981-07-21 AT AT81105755T patent/ATE12894T1/de not_active IP Right Cessation
- 1981-07-31 AR AR286315A patent/AR227931A1/es active
- 1981-09-02 DK DK388781A patent/DK154805C/da not_active IP Right Cessation
- 1981-09-15 ES ES505512A patent/ES8301640A1/es not_active Expired
- 1981-09-16 CS CS816830A patent/CS236470B2/cs unknown
- 1981-09-18 FI FI812920A patent/FI72654C/fi not_active IP Right Cessation
- 1981-09-18 AU AU75487/81A patent/AU527435B2/en not_active Ceased
- 1981-09-21 JP JP56147984A patent/JPS5782313A/ja active Granted
- 1981-09-23 DD DD81233513A patent/DD201754A5/de unknown
- 1981-09-23 PL PL23314481A patent/PL233144A1/xx unknown
- 1981-09-23 CA CA000386455A patent/CA1171787A/en not_active Expired
- 1981-09-23 NO NO813236A patent/NO153035C/no unknown
- 1981-09-23 HU HU812750A patent/HU186784B/hu unknown
- 1981-09-23 ZA ZA816594A patent/ZA816594B/xx unknown
-
1984
- 1984-11-26 US US06/674,366 patent/US4554156A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE3170119D1 (en) | 1985-05-30 |
| AR227931A1 (es) | 1982-12-30 |
| JPS6134829B2 (cs) | 1986-08-09 |
| ES505512A0 (es) | 1983-02-01 |
| ATE12894T1 (de) | 1985-05-15 |
| FI72654C (fi) | 1987-07-10 |
| AU527435B2 (en) | 1983-03-03 |
| DE3036033A1 (de) | 1982-05-06 |
| EP0048323A1 (de) | 1982-03-31 |
| NO813236L (no) | 1982-03-25 |
| ES8301640A1 (es) | 1983-02-01 |
| DK388781A (da) | 1982-03-25 |
| HU186784B (en) | 1985-09-30 |
| ZA816594B (en) | 1982-09-29 |
| DK154805C (da) | 1989-06-05 |
| FI72654B (fi) | 1987-03-31 |
| CA1171787A (en) | 1984-07-31 |
| US4554156A (en) | 1985-11-19 |
| PL233144A1 (en) | 1983-01-17 |
| EP0048323B1 (de) | 1985-04-24 |
| AU7548781A (en) | 1982-04-01 |
| NO153035C (no) | 1986-01-08 |
| FI812920L (fi) | 1982-03-25 |
| JPS5782313A (en) | 1982-05-22 |
| CS236470B2 (en) | 1985-05-15 |
| NO153035B (no) | 1985-09-30 |
| DK154805B (da) | 1988-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0048323B1 (de) | Wundbehandlungsmittel in Pulverform und Verfahren zu seiner Herstellung | |
| DE69326809T2 (de) | Alginatgel | |
| DE2623056C2 (de) | Verfahren zur Herstellung von festen wasserunlöslichen, in Methanol löslichen, hydrophilen Polymeren | |
| DE3305473C2 (de) | Verfahren zur Herstellung wasserunlöslicher, hydrophiler, elastomerer, druckempfindlicher Kleber und deren Verwendung | |
| DE3744289C2 (cs) | ||
| DE69519734T2 (de) | Gel enthaltender wundverband | |
| DE19646484C2 (de) | Flüssigkeitsabsorbierende Polymere, Verfahren zu deren Herstellung und deren Verwendung | |
| DE2615128A1 (de) | Zwischenpolymeres | |
| DE69020875T2 (de) | Oestrogenhaltiges Gelpräparat. | |
| DE2364675C2 (de) | Aus einer Polymerenhauptkette und Polymerenseitenketten bestehendes Copolymeres und seine Verwendung zur Herstellung von Gegenständen für biomedizinische Zwecke | |
| DE60313626T2 (de) | Antimikrobieller silberhaltiger wundverband f r kontinuierliche freisetzung | |
| DE69817574T2 (de) | Herstellungsmethode für ein faserfreies, poröses material | |
| DE3687415T2 (de) | Entfaerbungsfester hydrogelverband und verfahren. | |
| EP0040378B1 (de) | Mischung für halbstarre medizinische Stützverbände, damit erhaltene medizinische Binde und Verfahren zu deren Herstellung | |
| EP1909858B1 (de) | Hydrogel | |
| CH637833A5 (de) | Transparentes fluessigkeitsverbandmaterial, seine herstellung und verwendung. | |
| DE3128815A1 (de) | Polymeres verbundmaterial, seine herstellung und verwendung | |
| DE2933250A1 (de) | Abdeckmaterial | |
| LV10584B (en) | Aqueous-liquid and blood-absorbing powdery reticulated polymers, process for producing the same and their use as absorbents in sanitary articles | |
| LV10782B (en) | Powdery polymers absorbing water solutions and blood, method for producing and application therof in textilen for bodies hygiene | |
| DE3507775A1 (de) | Absorbierendes material sowie verfahren zu seiner herstellung und seine verwendung | |
| DE2725261C2 (de) | Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung | |
| DD145062A5 (de) | Transparentes fluessigkeitsverbandsmaterial | |
| DE112013006917T5 (de) | Carboxymethylcelluloseschaum zur hämostatischen Behandlung und zur Wundbehandlung und Verfahren zur Herstellung desselben | |
| DE3628482A1 (de) | Verfahren zur herstellung eines harzes mit hohem absorptionsvermoegen |